No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

byBryan SunandMinjee Kim

November 20, 2023

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

Walnut intake influences gut microbial gene expression

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

April 2, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]

Pharma

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

March 23, 2026

Few older adolescents meet recommended levels of physical activity

Weekly Rewinds

2 Minute Medicine Rewind March 2, 2026

March 2, 2026

Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Obeticholic acid for the treatment of non-alcoholic steatohepatitis

Pomegranate peel extract improved the metabolic profile of patients with non-alcoholic fatty liver disease

Variation in NICU antibiotic use not linked to outcomes

Ceftobiprole non-inferior to daptomycin in treating Staphylococcus aureus bacteremia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result